Arcus Biosciences, Inc. RCUS
- quemliclustat — Pancreatic Cancer Phase 3
CD73 (2 companies · 2 programs)
Companies with an active program directed at CD73.
Corvus Pharmaceuticals, Inc. CRVS
- mupadolimab
Companies with an active program directed at CD73.